Setmelanotide
Setmelanotide. MC4 receptor agonist approved for rare genetic forms of obesity.
How it works. Activates melanocortin-4 receptors in the hypothalamus, restoring the fullness signal that these gene defects break.
What the research supports. 2 graded claims. Strongest: Weight and hunger reduction in POMC or LEPR deficiency (strong).
Side effects and interactions. 0 medication interactions listed. Serious: Depression or suicidal thoughts (monitor).
Common forms. Available as Daily injection.
Community. Experiences from people who have tried Setmelanotide. Anecdotes are not medical advice.
Setmelanotide. MC4 receptor agonist approved for rare genetic forms of obesity.
What it is
Approved for obesity caused by POMC, PCSK1 or LEPR deficiency and for Bardet-Biedl syndrome. It is not a treatment for common obesity.
Also called
How it works
Activates melanocortin-4 receptors in the hypothalamus, restoring the fullness signal that these gene defects break.
Pathways
- MC4 receptor agonism
- Hypothalamic satiety signaling
Effects
- ↓Hunger decreases
- ↓Body weight (in eligible genetic conditions) decreases
- ↑Skin pigmentation increases
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
Side effects & interactions
Common side effects
- Skin darkening
- Injection-site reactions
- Nausea
Serious
- Depression or suicidal thoughts (monitor)
- Unwanted erections
No notable medication interactions listed.
Check any supplement–medication combination with your pharmacist before starting.
Common forms
- Daily injection
Discussion
Loading discussion…